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‡Simula Research Laboratory, Center for Biomedical Computing, Lysaker, NorwayABSTRACT Fibroblasts are electrophysiologically quiescent in the healthy heart. Evidence suggests that remodeling following
myocardial infarction may include coupling of myofibroblasts (Mfbs) among themselves and with myocytes via gap junctions. We
use a magnetic resonance imaging-based, three-dimensional computational model of the chronically infarcted rabbit ventricles
to characterize the arrhythmogenic substrate resulting from Mfb infiltration as a function of Mfb density. Mfbs forming gap junc-
tions were incorporated into both infarct regions, the periinfarct zone (PZ) and the scar; six scenarios were modeled: 0%, 10%,
and 30% Mfbs in the PZ, with either 80% or 0% Mfbs in the scar. Ionic current remodeling in PZ was also included. All prepa-
rations exhibited elevated resting membrane potential within and near the PZ and action potential duration shortening
throughout the ventricles. The unique combination of PZ ionic current remodeling and different degrees of Mfb infiltration in
the infarcted ventricles determines susceptibility to arrhythmia. At low densities, Mfbs do not alter arrhythmia propensity; the
latter arises predominantly from ionic current remodeling in PZ. At intermediate densities, Mfbs cause additional action potential
shortening and exacerbate arrhythmia propensity. At high densities, Mfbs protect against arrhythmia by causing resting depo-
larization and blocking propagation, thus overcoming the arrhythmogenic effects of PZ ionic current remodeling.INTRODUCTIONMyocytes, nonmyocytes, and the extracellular matrix are
key components of the myocardium. Myocytes are central
to the electromechanical function of the heart, but represent
only one-third to one-half of the cell population of healthy
adult myocardium. The remaining cells are nonmyocytes,
the majority of which are fibroblasts. The latter are electro-
physiologically quiescent and do not contribute to cardiac
electrical behavior under normal physiological conditions.
However, pathological conditions such as myocardial
infarction (MI) trigger electrical and fibrotic remodeling
of the myocardium, resulting in a substrate susceptible to
arrhythmias. Although electrical remodeling in surviving
myocytes includes primarily ion channel and gap junction
alterations (1,2), fibrotic remodeling is manifested as fibro-
blast proliferation and phenotypic switching, as well as
excess collagen deposition (3,4). Specifically, differenti-
ating fibroblasts, herein called myofibroblasts (Mfbs),
acquire a migratory phenotype by developing contractile
bundles, express a-smooth muscle actin, and exhibit altered
connexin distribution (5).
MI results in a scar (electrically inactive) and an adjacent
remodeled periinfarct zone (PZ) (2); the latter has been
shown to be critical in arrhythmogenesis (6–8). A variety
of mechanisms resulting from MI electrophysiological re-
modeling (e.g., slowed conduction due to ion channel and
gap junction modifications (9)) and the development of
fibrosis (e.g., functional discontinuities in the excitable
substrate due to collagen accumulation (10–12)) haveSubmitted February 28, 2011, and accepted for publication August 3, 2011.
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recent evidence suggests an additional mechanism: remod-
eled Mfbs may electrically couple both with myocytes and
among themselves in the infarct via gap junctions and
dynamically contribute to arrhythmia susceptibility
(3,13,14).
The functional coupling of Mfbs with themselves and
with myocytes is well established in cell culture (15–18).
However, it is difficult to electrically differentiate between
a cardiomyocyte and a well-coupled Mfb in situ due to the
Mfb’s very high membrane resistance, which causes it to
mirror the electrical activity of well-coupled myocytes
(19,20). Therefore, direct evidence of electrical myocyte-
Mfb and inter-Mfb coupling in the intact myocardium
remains difficult to obtain experimentally. Alternative
in situ experimental methods, including immunohistochem-
istry and dye transfer, have confirmed that a network of
coupled fibroblasts, possibly linked to adjacent myocytes,
exists in the rabbit sinoatrial node (20) and have established
that Cx43-expressing fibroblasts infiltrate damaged tissue
during progressive infarction, supporting the possibility
that Mfbs couple with themselves and with myocytes in
both the scar and PZ (21).
Due to the limitations associated with obtaining Mfb elec-
trophysiological measurements in the intact myocardium,
computational modeling has emerged as an important tool
capable of determining the arrhythmogenic role that inter-
Mfb and Mfb-myocyte coupling would play if these electri-
cal connections do, in fact, form in the myocardium under
disease conditions. Previous computational studies using
cellular-level and two-dimensional tissue models showed
that Mfbs coupled to myocytes have the capability ofdoi: 10.1016/j.bpj.2011.08.009
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as well as the conduction and upstroke velocities in
surrounding tissue (22–27), thus suggesting a possible role
of Mfb-myocyte coupling in perturbing the electrical
activity in diseased hearts.
The goal of this study is to explore the possible role of
inter-Mfb and Mfb-myocyte electrical coupling in the scar
and PZ in the mechanisms of arrhythmia generation under
the conditions of MI. To achieve this goal, a novel, to our
knowledge, magnetic resonance imaging (MRI)-based bio-
physically detailed three-dimensional (3D) computational
model of the infarcted rabbit ventricles is developed. Simu-
lations are conducted to characterize the arrhythmogenic
substrate resulting from inter-Mfb and Mfb-myocyte
coupling for varying degrees of Mfb infiltration in the PZ
and scar. Simulations are then performed to assess the
various substrates’ propensity to arrhythmia.FIGURE 1 Model generation. Representative MRI slice of the rabbit
heart, segmentation of the slice, and whole heart mode.METHODS
Model generation
We have recently developed a high-throughput pipeline for the generation
of 3D models of hearts from ex vivo structural magnetic resonance (MR)
and diffusion tensor (DT) MR images (28–30). This pipeline was used in
the creation of the infarcted rabbit heart model used in this study.
A rabbit heart at 7.5 weeks postinfarction was scanned (MR and DTMR)
at a resolution of 61  61  60 mm3, as described in (29); a representative
long-axis slice of the MR image stack is shown in Fig. 1. The scar and PZ
were differentiated from the healthy myocardium and segmented out as
described in (29) (Fig. 1). The segmented images were used to generate
the finite element mesh of the ventricles using the meshing package Taran-
tula (CAE-Software Solutions, Eggenburg, Austria); the methodology is
described in (31). Each element of the 4.1 million node mesh (average
edge lengths: 60 mm in the PZ/scar, 171 mm in healthy tissue) was assigned
a fiber orientation based on the calculation of the primary eigenvector of the
DT obtained from the DTMR data, as described in (29).Representing infarction-related structural
remodeling
The PZ was modeled as containing 0% (PZ0), 10% (PZ10), or 30% (PZ30)
Mfbs by volume, thus including the range of densities previously quantified
in sheep heart PZ tissue over a 30-day postinfarction period (21). This was
achieved by assigning Mfb properties, at random distribution, to
a percentage of PZ elements in the model. Because the average PZ element
edge length is 60 mm, each Mfb-assigned element actually represents
a small cluster of interconnected Mfbs due to their small size (620 mm2
average area corresponding to an average cell length ~25 mm) (32).
Although the scar is known to be densely fibrotic, the question of whether
Mfbs in the scar form an interconnected network via electrical coupling or
simply act as passive barriers to conduction remains unanswered (21).
Therefore, the scar was modeled in two ways: with either 80% Mfbs by
volume (Scar80), with the remainder as insulator, or as 100% insulator
(Scar0). Thus, a total of six versions of the ventricular model were created
when combining the three cases of Mfb density in the PZ with the two cases
of Mfb density in the scar: Scar0PZ0, Scar80PZ0, Scar0PZ10, Scar80PZ10,
Scar0PZ30, and Scar80PZ30. The case for which the PZ contained no
Mfbs and the scar was purely insulator (Scar0PZ0) was considered to be
the control.Biophysical Journal 101(6) 1307–1315Representing electrophysiological properties
in the model
Mathematical description of current flow in cardiac tissue in the rabbit
ventricles was based on the monodomain representation. Myocyte
membrane kinetics was represented by Mahajan et al.’s model of the rabbit
ventricular AP (33). In the PZ, the myocyte’s membrane kinetics was modi-
fied to match data reported in the literature. Previous investigations of PZ
remodeling in infarcted hearts found reductions in peak currents as follows:
Naþ (INa) to 38% of the normal value (9); L-type Ca
2þ (ICa,L) to 31% of
normal (34); and rapid (IKr) and slow (IKs) components of the delayed recti-
fier to 30% and 20% of maximum (35), respectively. For the purpose of
differentiating between the electrophysiological consequences of Mfb pres-
ence in the PZ versus ionic current remodeling in the PZ, additional ventric-
ular models were created with Mfb presence but without ionic current
remodeling in the PZ (Scar% PZ%
no-ionic). In all models, Mfb membrane
kinetics in PZ and scar were represented by the MacCannell model (22),
which includes inwardly rectifying (Kir) and time- and voltage-gated (Kv)
Kþ currents, and a resting membrane potential (VREST) of 49.6 mV.
The three regions of the model (healthy tissue, PZ, and scar) were
assigned different conductivities based on recent experimental data.
Specifically, healthy myocardium was assigned conductivities such that
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rabbit myocardium (36–38); conductivities of 0.163 S/m in the primary my-
ofiber direction and 0.025 S/m in the cross-fiber direction resulted in a mean
CVof 47.9 cm/s in healthy tissue, matching the recorded value of 49.0 cm/s
reported in normal rabbit myocardium (38). PZ myocytes were assigned
conductivity values that were 90% (longitudinal) and 8.5% (transverse)
of that of healthy tissue to match measured changes in gap junctional
conductance (39). PZ Mfbs were modeled as isotropic with reduced
conductivity (75% of that of healthy myocardium’s primary fiber direction),
representing the reduction of single gap junction conductance measured in
Mfb-myocyte pairs as compared to intermyocyte junctions (15). Similarly,
Mfbs in the scar were assigned a conductivity value 50% of that of healthy
tissue in the primary fiber direction, thus accounting for the decrease in gap
junction conductance measured between two Mfbs as compared to two
myocytes (15).FIGURE 2 (A) VREST maps in the models. 0% (top row) or 80% (bottom
row) Mfbs in the scar region. 0% (left column), 10% (middle column), or
30% (right column) Mfbs in the PZ. Average PZ VREST values and standard
deviations are listed below the respective preparations (B). Boxplots of
VREST in PZ of each substrate. Whiskers represent minimum and maximum
of all values in a given preparation.Simulation protocol and data analysis
To achieve steady state in the ventricles, ionic model state variables were
first precomputed in a single cell by pacing until a steady state was reached.
Next, the ventricular models were paced for 5 beats at 300 ms cycle length
from a site on the endocardium far removed from the infarct.
Because Mfbs have a less negative resting potential than myocytes,
coupling between the two cell type models elevates the myocyte’s resting
potential (24). Indeed, experimental results have shown that cardiomyocyte
strands coated in Mfbs undergo a Mfb density-dependent gradual depolar-
ization (14). Thus, to characterize the diastolic potential distribution, maps
of VREST were constructed for each model.
AP duration (APD) dispersion increases susceptibility to arrhythmia
(40,41). Although ionic current remodeling of the PZ has been demon-
strated to cause APD dispersion (6,34,42), Mfbs have also been found to
lead to APD shortening in adjacent myocytes (9,18,22,24,25,34,35). To
characterize APD dispersion in each ventricular model, APD maps were
generated by calculating the duration from peak AP amplitude to 60% repo-
larization (APD60) at each node in the ventricular mesh, a level that allows
for comparison of APD under conditions of elevated VREST. Additionally, to
assess the sole effect of Mfb coupling on APD, APD distribution was exam-
ined in preparations without ionic current remodeling in the PZ.
To assess the arrhythmogenic propensity of the different ventricular
models, a programmed electrical stimulation (PES) protocol was used to
induce arrhythmias (43,44). The protocol consisted of pacing for 5 beats
at 300 ms cycle length, followed by two premature stimuli (S2 and S3) at
various coupling intervals (165–180 ms for S2, 115–180 ms for S3) after
the last pacing stimulus (S1). The pacing electrode was located at the endo-
cardial apex, a common site for PES. In all cases activity was simulated for
2.5 s following S3. Arrhythmia induction was defined as the formation of
a reentrant circuit, which completed a minimum of one cycle.RESULTS
Characterization of the electrophysiological
properties in the ventricles arising from inter-Mfb
coupling in the scar and Mfb-myocyte coupling
in the PZ
Increasing Mfb density results in a progressive elevation of
PZ resting potential
Fig. 2 A displays maps of VREST distribution for each of the
ventricular models. Incorporation of Mfbs of increasing
densities in both scar and PZ results in the progressive eleva-
tion of PZ VREST from 87.8 mV (Scar0PZ0) to 75.1 mV
(Scar80PZ30). The boxplots in Fig. 2 B depict the distributionof VREST in each ventricle’s PZ; the middle 50% of the PZ’s
VREST values (represented by each box) cover a wider range
and exhibit less negative values as Mfbs are either added to
the scar or PZ Mfb densities are increased. Likewise, the
largest degree of resting tissue depolarization (indicated
by the rightmost whisker of each plot) occurs in ventricular
models that incorporate inter-Mfb coupling in the scar, with
further increase in maximum resting depolarization as Mfb
densities are increased in the PZ. The model with the largest
number of Mfbs (Scar80PZ30) has the greatest degree of
resting depolarization, reaching up to 61 mVas compared
to the control’s VREST of 87.8 mV. The VREST map of this
densely fibrotic preparation (Fig. 2 A, lower right) exhibits
maximum resting depolarization at the core of the intercon-
nected Mfb network (arrow), and thus at the point farthest
away from any myocyte connections.
Inter-Mfb coupling in the scar and Mfb-myocyte coupling
in the PZ lead to heterogeneous APD shortening in the
ventricles
APD distribution maps for the six ventricular models are
displayed in Fig. 3 A. In the control preparation (Scar0PZ0),
APD shortening of ~25 ms occurs in the PZ as a result of
ionic current remodeling, consistent with rabbit experi-
mental findings (45). Therefore, to isolate the Mfb’s poten-
tial shortening effect on APD, APD distributions for each of
the six preparations were additionally calculated withoutBiophysical Journal 101(6) 1307–1315
FIGURE 3 APD maps in the models (A) and
those when ionic current remodeling in the PZ is
removed (B). 0% (top row) or 80% (bottom row)
Mfbs in the scar region. 0% (left column), 10%
(middle column), or 30% (right column) Mfbs in
the PZ. The average APD and its standard devia-
tion are listed below each preparation. Boxplots
represent distribution of APD in the PZ (C) and
healthy tissue (D) for both sets of models.
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ents the gradual decrease in average APD throughout the
tissue (value listed below each map) as Mfb density is
increased in either PZ or scar, ranging from 130.9 ms
(Scar0PZ0
no-ionic) to 81.9 ms (Scar30PZ80
no-ionic). Mfb-
induced APD shortening occurs in a spatially heterogeneous
fashion—the locations with the shortest APD (green) are
nearest to the scar and PZ (refer to Fig. 4 for PZ and scar
locations). Largest APD values occur in healthy regions
farthest from the infarct and are consistent in all models,
including Scar0PZ0
no-ionic. Comparing Fig. 3 B (APD distri-
bution due solely to Mfbs) to Fig. 3 A (APD distribution due
to Mfbs and ionic current remodeling), one finds that Mfb
infiltration, with or without ionic current remodeling in
the PZ, results in the same trend of APD shortening.
Although average APD in the Scar0PZ0 model (112.8 ms)
is shorter than that in Scar0PZ0
no-ionic (130.9 ms), a progres-
sive decrease in average APD is still observed as Mfb
density is increased in either the PZ or scar, reaching the
shortest average duration of 81.9 ms in both the Scar80PZ30
and Scar80PZ30
no-ionic models.
APD distribution is quantified in PZ and healthy tissue in
Fig. 3, C and D, respectively, with data compared, in eachFIGURE 4 VREST and APD as a function of distance along the vertical
line between points A (in the outer edge of the PZ) and B (10 mm removed
from the outer edge of the PZ) in the Scar80PZ30 model.
Biophysical Journal 101(6) 1307–1315case, to that without ionic current changes in the PZ. At
lower Mfb densities, the Mfb’s APD shortening effect is
augmented by the APD shortening due to ionic current re-
modeling in the PZ, as evidenced by a left shift of the
Scar80PZ0 data’s white box (representing data from PZ tissue
with ionic current remodeling) compared to its gray box (rep-
resenting data from PZ tissue without ionic current changes)
in Fig. 3 C. As Mfb densities are increased in the models, an
increasing portion of PZ tissue does not activate (compare
black regions in Fig. 3 A). Because inactivated tissue is not
included in the boxplot calculations, the PZ APD for these
models (Scar80PZ10, Scar0PZ30, and Scar80PZ30) is shortened
to a lesser degree as Mfb densities increase (Fig. 3 C, slight
right shift of boxes for the top three models). As Mfbs are
added to the PZ or scar in these three cases, PZ myocytes,
which previously exhibited a very short APD, become inac-
tivated and therefore, no longer contribute to the shortening
trend in the APD data for that model. As more PZ tissue
becomes inactivated, less excitable tissue remains in close
proximity to Mfbs, resulting in less tissue experiencing the
highest degrees of APD shortening.
VREST and APD were calculated as functions of distance
from the PZ for the Scar80PZ30 model at the locations shown
in Fig. 4. VREST exhibits a sharp drop-off with distance away
from the PZ, reaching 90% of the average control value over
a short distance of 2.2 mm. Thus, the partial INa inactivation
that results from membrane depolarization (and may
contribute to conduction block) is confined to the infarct
regions and tissue within close proximity to the PZ. APD,
on the other hand, attenuates with distance from PZ at
a slower rate; APD restoration to 90% of the average control
value occurs over a distance of 5.3 mm. That said, tissue in
regions farthest from the PZ and scar remains unaffected by
the Mfbs; maximum APD in healthy tissue (as indicated by
the rightmost whiskers in Fig. 3 D) is 144 ms in all prepara-
tions, including control.
TABLE 2 Outcomes of PES on ventricles without ionic





Scar0 No Arrhythmia Arrhythmia No Arrhythmia
Scar80 No Arrhythmia Arrhythmia No Arrhythmia
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from inter-Mfb and Mfb-myocyte coupling
Low Mfb densities do not alter the propensity to arrhythmias
PES was used to assess each substrate’s susceptibility to
reentry. Because ionic current changes in the PZ and Mfbs
in the infarct both create potentially arrhythmogenic APD
dispersion (Fig. 3, A and B), reentry generation in prepara-
tions both with and without PZ ionic current remodeling
was examined. Outcomes of PES are summarized in Tables 1
and 2, respectively. All induced arrhythmias were unsus-
tained, consistent with experimental evidence; pharmaco-
logical intervention is necessary to induce sustained
arrhythmias in the chronic MI rabbit ventricles (38). In the
Scar0PZ0
no-ionic model (Table 2, at top left), where no elec-
trophysiological remodeling (ionic current changes in PZ or
Mfb infiltration) takes place, S3 encounters tissue of
uniform recovery and results in either complete conduction
block or undisturbed propagation, depending on the S3
coupling interval. In the Scar0PZ0 preparation (Table 1, at
top left), arrhythmia induction following PES is due exclu-
sively to ionic current remodeling in the PZ, as no Mfbs are
present in the preparation. As shown in Fig. 3 A (at top left),
PZ ionic current remodeling alone creates APD dispersion
and results in arrhythmia, as demonstrated by a body of
experimental research (40,41). Adding 80% Mfbs to the
scar results in the same differences in the outcome of PES
(compare Tables 1, lower left, with Table 2, lower left), indi-
cating that low levels of Mfb infiltration are not a major
player in post-MI ventricular arrhythmogenesis.
Intermediate levels of Mfb infiltration increase arrhythmia
susceptibility via APD dispersion
In all substrates with 10% Mfbs by volume in the PZ (with
and without PZ ionic current remodeling), PES results in
arrhythmia induction, which is caused by APD dispersion,
as characterized in Fig. 3. In those substrates without PZ
ionic current remodeling (middle column of Table 2),
Mfbs themselves generate sufficient APD dispersion to
support arrhythmogenesis. In the presence of PZ ionic
current remodeling (middle column of Table 1), Mfbs
contribute synergistically to the induction of arrhythmia.
This is illustrated in the top row of Fig. 5, which displays
snapshots of transmembrane potential maps in a cross-
sectional view of the Scar80PZ10 ventricles following PES
(see Movie S1 in the Supporting Material). S3 results in
unidirectional block (black line) and transmural reentry
(manifested as breakthrough activity on the endocardialTABLE 1 Outcomes of PES on ventricles with ionic current
remodeling in the PZ
PZ0 PZ10 PZ30
Scar0 Arrhythmia Arrhythmia No Arrhythmia
Scar80 Arrhythmia Arrhythmia No Arrhythmiasurface) due to the APD dispersion concurrently generated
by Mfbs and PZ ionic current remodeling.
High levels of Mfb infiltration protect against reentrant activity
via VREST elevation
As apparent from the right columns in Tables 1 and 2,
increasing PZ Mfb density to 30% by volume protects the
preparation from arrhythmia induction, regardless of ionic
current remodeling in the PZ (Table 1). Thus, high levels
of Mfb infiltration have an opposite effect on arrhythmogen-
esis than intermediate levels. The bottom row of Fig. 5 illus-
trates the failure of arrhythmia induction in the Scar80PZ30
preparation (see Movie S2), arising from conduction failure
due to the higher VREST elevation as compared to the
Scar80PZ10 case. VREST elevation, caused by PZ Mfb-
myocyte coupling (Fig. 2) causes partial INa inactivation
and contributes to conduction failure (14,46). Overall, prep-
arations with the highest VREST elevation (Scar0PZ30 and
Scar80PZ30, as seen in Fig. 2 B) are also those that exhibit
conduction failure of S3 and thus do not result in arrhythmia
(right column, Table 1). Therefore, the antiarrhythmic effect
of VREST elevation counteracts the proarrhythmic APD
dispersion created by both the Mfbs and the PZ ionic current
remodeling.DISCUSSION
The goal of this study was to examine the role of inter-Mfb
and Mfb-myocyte electrical coupling in the scar and PZ in
establishing the arrhythmogenic substrate in MI. Propensity
to arrhythmia following PES was evaluated as a function
of Mfb density in the infarcted ventricles. It was found
that the Mfbs’ contribution to arrhythmia propensity is a
function of Mfb density. At low densities, Mfbs do not alter
arrhythmia susceptibility, which is determined exclusively
by PZ ionic current remodeling. At intermediate densities,
Mfbs act synergistically with PZ ionic current remodeling
to support arrhythmogenesis by creating additional APD
dispersion. At high densities, Mfbs cause resting depolariza-
tion sufficient to suppress the propensity to reentry, despite
other proarrhythmogenic effects.
To the best of our knowledge, this study is the first to use
a high-resolution MRI-based 3D model of the infarcted
ventricles in a study of electrophysiological mechanisms
associated with the Mfb infiltration levels in the infarct.
The model structure is highly detailed, including papillary
muscles and trabeculations. Realistic scar and PZ mor-
phology as well as fiber architecture are implementedBiophysical Journal 101(6) 1307–1315
FIGURE 5 Transmembrane potential maps of
arrhythmia (top row) and termination of conduc-
tion (bottom row) at four time instants in two prep-
arations. Cross-sectional views show endocardial
surfaces for the right and left ventricles (RV and
LV, respectively, marked at bottom right). Red
arrows indicate the location of S3 on the endocar-
dial apex. Line of unidirectional block is marked in
black. Conduction direction is indicated by the
black arrows.
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combined with the small spatial discretization aimed at
resolving the presence of Mfbs (or small Mfb clusters),
and with a complex ionic model featuring Markovian
calcium handling, represents possibly the most sophisti-
cated 3D model of the infarcted ventricles to date.The Mfb’s role as a current sink and source
Numerous studies, both experimental and computational,
have aimed to determine the electrophysiological effects
of myocyte-Mfb coupling on cardiomyocyte electrophysio-
logical properties. None, however, have investigated the
ensuing arrhythmogenic effects in the realistic 3D substrate
resulting from MI. As this study confirmed, the roles of the
Mfb as a current sink and current source act synergistically
to promote or protect against arrhythmia susceptibility:
Current sink. During cardiomyocyte AP upstroke and
plateau, coupled Mfbs act as passive load, as a result
of their time and voltage-dependent outward Kþ
currents (47,48), sinking current from neighboring
excited myocytes. Previous modeling studies
(22,24,25) have shown that coupling of Mfbs to
ventricular myocytes shortens the myocyte APD
when the Mfb’s VREST is sufficiently low (~49 mV,
as presented here). In this study, the role of the Mfb
as an electrophysiological current sink underlies the
APD shortening experienced by the myocardium.
Current source.Mfbs have a relatively depolarizedVREST
compared to that of cardiomyocytes. In vitro studies
have found that Mfbs act as a current source, causing
diastolic depolarization of the connected myocytes
(14), which may give rise to ectopic excitationBiophysical Journal 101(6) 1307–1315(49–51). In this study, theMfb’s role as a current source
results in VREST elevation in PZ. The resulting partial
sodium channel inactivation contributes to conduction
failure when PZ Mfb densities are relatively high.Mfb densities modulate arrhythmogenesis
The Mfb’s dual role as a current source and sink, as
described previously, results in APD dispersion and VREST
elevation in substrates with electrical inter-Mfb and Mfb-
myocyte connections in the scar and PZ. The unique combi-
nation of these consequences resulting from the specific
Mfb density, combined with the particular structure of the
infarct, contributes to or protects against the substrate’s
susceptibility to arrhythmia. At relatively low densities
(Scar0PZ0 and Scar80PZ0), Mfbs do not alter arrhythmia
propensity; the latter results from APD dispersion stemming
from PZ ionic current remodeling. When Mfbs are present at
intermediate densities (Scar0PZ10 or Scar80PZ10), however,
the additional APD dispersion caused by the Mfbs’ role as
current sinks exacerbates arrhythmia propensity. At higher
Mfb density the scale is tipped to an antiarrhythmic
behavior as the Mfbs act as current sources causing resting
depolarization; it overcomes the PZ ionic current remodel-
ing arrhythmogenic effect and prevents the establishment
of reentry.
Experimental evidence indicates that remodeling in the
PZ alone underlies the mechanisms for arrhythmogenesis
in the post-MI heart (7,44,52). Likewise, several experi-
mental studies suggest that Mfb-myocyte coupling can
contribute to arrhythmia propensity (3,14,17,27). In our
study, both classes of mechanisms are manifested; we
dissect their interplay as a function of Mfb density. Research
Myofibroblasts Alter Arrhythmogenesis 1313has reported that mouse survival rates during the first month
after MI is highest during the first 6 days (53), correspond-
ing to the time that Mfbs show maximal accumulation in
mouse infarct tissue (54); this evidence supports our finding
that Mfbs at high densities have an antiarrhythmic effect. As
mouse infarct Mfb densities begin to decrease significantly
at day 7 (54), survival rates for postinfection mice plummet
(53); this corroborates our finding that intermediate levels of
Mfbs exacerbate arrhythmogenesis. Finally, mouse survival
rates have been documented to proceed at a steady rate after
day 15 (53), a time frame during which Mfb densities are
very low (54), suggesting that arrhythmogenesis is not due
to Mfb infiltration.
In certain conditions, such as those associated with aging
or genetic disease, myocardial fibrotic remodeling (and
proliferation of Mfbs) might occur without concomitant
ionic current remodeling (3). Because aging is positively
correlated with increased incidence of ventricular
arrhythmia, even when excluding populations with coronary
artery disease (55), it is feasible that Mfbs could underlie ar-
rhythmogenicity in aged hearts. We speculate that such
conditions would correspond to the effect of intermediate
Mfb densities because the distribution of Mfbs is diffuse
in fibrosis (56).
Studies on cultured strands of cells have found that Mfbs
at high densities cause ectopic excitation as the myocyte’s
VREST elevates (due to the Mfb’s inherently high VREST)
and surpasses the myocyte’s activation threshold (51). In
the current study, however, maximal VREST elevation rea-
ches 60.7 mV, well below the used myocyte model’s fast
sodium channel activation threshold of 40 mV (33); no
automaticity was observed. It is possible that increasing
Mfb levels beyond the high densities used here could result
in ectopic activity, thus adding another layer of complexity
to the Mfb’s influence presented herein. In our study,
however, Mfb densities were assigned in the model as
low, intermediate, and high based on in vitro experimental
data (21), thus we did not represent high Mfb densities as
could be found in cultured strand studies.
In vitro studies have found that Mfbs alter their electro-
physiological contribution as a function of density, consis-
tent with the findings presented here. Specifically, Morita
et al. (57) used histological analysis to measure the
percentage of area occupied by fibrosis (compared to total
area) at sites of early afterdepolarization (EAD) origination
in aged hearts; it was found that sites of frequent EAD orig-
ination had an intermediate percent fibrosis (mean of 28%)
compared to other regions of the heart. Likewise, the two-
dimensional computational model of fibrosis (including
Mfb-myocyte coupling) used to further elucidate their find-
ings found that an intermediate range of Mfb/myocyte cell
number ratios supported EADs and repetitive triggered
activity, whereas high and low did not (57). Similarly,
Zlochiver et al. (27) used Cx43 silencing and overexpression
techniques to modify the degree of Mfb-myocyte couplingin heterocellular cocultures; CV was found to have
a biphasic dependency on Mfb Cx43 expression levels,
and thus on electrical coupling, whereby CV initially
decreased and then increased as heterocellular coupling
levels increased. Increasing heterocellular coupling is anal-
ogous to increasing Mfb density, as both result in APD
shortening and VREST elevation. Miragoli et al. (14) found
that an increase in Mfb/myocyte ratios up to 7:100 caused
an increase in both CV and maximal upstroke velocity,
followed by a progressive decline at higher ratios.
The antiarrhythmic behavior of Mfbs at high densities
opens a new door for therapeutic targets. A pharmacological
agent that increases gap junction conductance between my-
ocytes and Mfbs would enhance the Mfb’s ability to act as
a current source at rest, which could prevent reentrant
activity. Research is under way to design peptides that can
prevent closure of Cx43 gap junctions between myocytes
(58,59) because reduced Cx43 expression among myocytes
in the PZ is thought to underlie disruption of conduction
(51,52). This novel treatment of cardiac arrhythmias could
be extended based on our findings to involve targeting of
Mfb-myocyte gap junctions.Study limitations
Although it is agreed upon that Mfbs have a relatively
elevated VREST compared to that of cardiomyocytes, the
actual value is debated (15,22,60). If the Mfb’s VREST is
different than the one used here (49.6 mV), it may affect
APD distribution and thus conduction block and reentry
initiation; however, the mechanisms uncovered here will
remain valid. Furthermore, our continuum finite element
model does not resolve individual cells, and the need for
computational tractability of this large model prevents the
decrease in the spatial discretization of the PZ and scar
beyond element edge lengths of 60 mm (larger than
a Mfb). Thus, we are unable to model individual Mfbs scat-
tered among larger myocytes; instead, our model represents
clusters of a few interconnected Mfbs scattered among
larger myocytes. However, because it has previously been
shown in vitro that interconnectedMfbs can serve as a bridge
for electrical connection between myocyte groups over
distances of up to 300 mm (5 as long as the average
edge length in the PZ and scar) (17), it is unlikely that
this modeling methodology would produce different results
regarding the contribution of Mfbs to arrhythmogenesis
in MI.
Our model does not account for transmural heterogeneity
of ion channel expression, which would cause APD disper-
sion across the transmural wall. However, because the Mfb’s
influence on APD reported herein is much greater than the
difference in APD experienced across the transmural wall
in the adult rabbit (~21 ms (61)), it is unlikely that such
inclusion will alter the uncovered mechanisms. Likewise,
the His bundle and Purkinje network are not representedBiophysical Journal 101(6) 1307–1315
1314 McDowell et al.in the model to limit model complexity. This is a reasonable
simplification because we assess arrhythmogenesis
following PES; experimental studies have shown that the
Purkinje network does not play a role under such circum-
stances (62,63). Furthermore, this study was performed
using one MI rabbit heart model. Although the specific
pattern of the reentrant arrhythmia is likely to be different
in different infarcted hearts, we expect that the basic mech-
anisms of arrhythmogenesis associated with Mfb-myocyte
coupling uncovered here will remain valid regardless of
the specific infarct morphology.
Finally, the distinction between an activated fibroblast
and a myofibroblast is debatable. Some argue that the devel-
opment of contractile bundles does not necessarily trans-
form the fibroblast into a new cell type, and therefore do
not acknowledge the myofibroblast as a distinct cell type
(64). Thus, what we refer to herein as a myofibroblast
(Mfb) may represent what others see as a specific fibroblast
phenotype. Because we are unaware of a mathematical
model that fully represents the myofibroblast, we have
chosen to represent this cell type with MacCannell et al.’s
ionic model of an active fibroblast phenotype, which
includes time- and voltage-gated Kþ currents (22). The
model choice seems suitable for an electrophysiological
study because inwardly rectifying Kþ (Kir) current densities
were found to be the same between myofibroblasts and
fibroblasts with measurable Kir currents (48). However,
further studies are needed to fully elucidate the electrophys-
iological differences between activated fibroblasts and
myofibroblasts.SUPPORTING MATERIAL
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